You are here

  • Home
  • Archive
  • Volume 30, Issue 6
  • Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence

Article info

Article menu
Download PDFPDF
PostScript
Letter
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence

Authors

  1. Correspondence to Dr Daniele Mengato, Hospital Pharmacy, Padua University Hospital, Padova 35121, Italy; daniele.mengato{at}gmail.com
View Full Text

Citation

Trivellato S, Mengato D, Donà D, et al
Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence
European Journal of Hospital Pharmacy 2023;30:e33.

Publication history

  • First published October 6, 2022.
Online issue publication 
February 06, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© European Association of Hospital Pharmacists 2023. No commercial re-use. See rights and permissions. Published by BMJ.